Pacific Global Investment Management CO Seagen Inc. Transaction History

Pacific Global Investment Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$127.59 - $203.08 $165,867 - $264,004	1,300 New	1,300 $263,000
Q2 2022 Aug 05, 2022	BUY	$108.81 - $179.33 $141,453 - $233,129	1,300 New	1,300 $230,000
Q1 2022 Apr 25, 2022	SELL	$119.61 - $157.85 $155,493 - $205,205	-1,300 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $175,604 - $209,430	1,300 New	1,300 $205,000
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $178,763 - $248,040	-1,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $214,019 - $275,509	1,300 New	1,300 $228,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Pacific Global Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Pacific Global Investment Management CO with notifications on news.